Sonosensitization
AssigneeSonalaSense, Inc.
InventorStuart L. MARCUS
Life of this patent
Estimating the term…
Abstract
An improved method for MRI-guided sonosensitized focused ultrasound treatment of malignant tissue is disclosed herein.
Claims42
A method for treating diffuse intrinsic pontine glioma in a human subject in need thereof, comprising selectively inducing a directly cytotoxic effect or apoptosis within diffuse intrinsic pontine glioma tissue in a subject, the method comprising:
- a) intravenously administering from 5 mg/kg to 750 mg/kg of gamma-irradiated 5-aminolevulinic acid (5-ALA), or a pharmaceutically acceptable salt thereof, to the subject;
- and
- b) exposing the tissue to ultrasound energy (“sonicating”) using a focused ultrasound (FUS) device, at a frequency of about 0.1 MHz to about 3 MHZ, at an intensity at the ultrasound beam focus of about 3 W/cm2 to about 100 W/cm2, wherein the tissue is sonicated at a plurality of individual points.
(canceled)
(canceled)
(canceled)
(canceled)
The method of claim 19, wherein there is an incubation period between administering the 5-ALA and sonicating the tissue.
13-15. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
33-37. (canceled)
The method of claim Error! Reference source not found, wherein the microbubbles are enhanced contrast ultrasound microbubbles.
40-44. (canceled)
(canceled)
52-59. (canceled)
Dependencies are inferred from the claim text.